Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Bluejay Diagnostics Inc. (BJDX:NASDAQ), powered by AI.
Bluejay Diagnostics Inc. is currently trading at $4.57. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Bluejay Diagnostics Inc. on Alpha Lenz.
View Bluejay Diagnostics Inc.'s valuation metrics on Alpha Lenz.
“Bluejay Diagnostics Inc.'s ROE is -117.0%. Explore profitability and growth together.”
Ask for details →Bluejay Diagnostics Inc. is a biotechnology company specializing in developing compact, point-of-care diagnostic systems. Its primary function is to create innovative solutions that enable rapid and accurate testing, particularly in decentralized healthcare settings like doctor's offices or clinics. The company focuses on leveraging advanced technology to deliver cost-effective and efficient diagnostic results, allowing healthcare providers to make informed clinical decisions quickly. Bluejay Diagnostics is significant in the biotechnology and healthcare sectors as it aims to improve patient outcomes through its state-of-the-art detection systems, thereby enhancing diagnostic capabilities. The company operates in a growing market segment that emphasizes accessible and immediate healthcare solutions, reflecting a shift towards personalized and real-time patient care.
“Bluejay Diagnostics Inc.'s ROE is -117.0%. Explore profitability and growth together.”
Ask for details →Bluejay Diagnostics Inc. (ticker: BJDX) is a company listed on NASDAQ in the Healthcare sector (Medical Devices). It has approximately 5 employees.
The current price is $4.565 with a P/E ratio of -x and P/B of -x.
ROE is -117.02%.